Amphotericin B liposomal

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Amphotericin B liposomal is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Empiric therapy for presumed fungal infection in patients with febrile neutropenia
  • Visceral leishmaniasis

NON-FDA APPROVED USES

  • Zygomycetes and other invasive molds
  • Coccidioidomycosis
  • Histoplasmosis

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 26, 2017